Literature DB >> 11674356

Acylnitrene Route to Vicinal Amino Alcohols. Application to the Synthesis of (-)-Bestatin and Analogues.

Stephen C. Bergmeier1, Dionne M. Stanchina.   

Abstract

Bestatin, valinoctin A, and microginin are naturally occurring small peptides containing a nonproteinogenic alpha-hydroxy-beta-amino acid at the N-terminus of the peptide chain. We report here our development of a general method for the synthesis of alpha-hydroxy-beta-amino acids and exemplify this with a synthesis of (-)-bestatin and analogues. Our synthesis utilizes an intramolecular acylnitrene-mediated aziridination to generate a key bicyclic aziridine in excellent yield and stereoselectivity. This bicyclic aziridine can be opened with a number of organometallic reagents to provide a series of substituted oxazolidinones. The oxazolidinones are readily converted to bestatin and a series of bestatin analogues. As part of this approach, we have developed a new method for the synthesis of azidoformates. We have also demonstrated that oxazolidinones can be selectively hydrolyzed in the presence of peptide bonds. This acylnitrene route to bestatin should prove useful for the synthesis of a variety of analogues of bestatin as well as other alpha-hydroxy-beta-amino acids and their corresponding peptides.

Entities:  

Year:  1999        PMID: 11674356     DOI: 10.1021/jo9823893

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  11 in total

1.  A stereoselective synthesis of the bromopyrrole natural product (-)-agelastatin A.

Authors:  Paul M Wehn; J Du Bois
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

2.  Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.

Authors:  Crina M Orac; Shu Zhou; John A Means; David Boehm; Stephen C Bergmeier; Jennifer V Hines
Journal:  J Med Chem       Date:  2011-08-31       Impact factor: 7.446

3.  Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase.

Authors:  Geetha Velmourougane; Michael B Harbut; Seema Dalal; Sheena McGowan; Christine A Oellig; Nataline Meinhardt; James C Whisstock; Michael Klemba; Doron C Greenbaum
Journal:  J Med Chem       Date:  2011-03-02       Impact factor: 7.446

4.  Asymmetric Radical Bicyclization of Allyl Azidoformates via Cobalt(II)-Based Metalloradical Catalysis.

Authors:  Huiling Jiang; Kai Lang; Hongjian Lu; Lukasz Wojtas; X Peter Zhang
Journal:  J Am Chem Soc       Date:  2017-06-29       Impact factor: 15.419

5.  Visible-light sensitization of vinyl azides by transition-metal photocatalysis.

Authors:  Elliot P Farney; Tehshik P Yoon
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-26       Impact factor: 15.336

6.  Enantioselective total synthesis of brevetoxin A: unified strategy for the B, E, G, and J subunits.

Authors:  Michael T Crimmins; J Michael Ellis; Kyle A Emmitte; Pamela A Haile; Patrick J McDougall; Jonathan D Parrish; J Lucas Zuccarello
Journal:  Chemistry       Date:  2009-09-14       Impact factor: 5.236

7.  Enzymatic C(sp3)-H Amination: P450-Catalyzed Conversion of Carbonazidates into Oxazolidinones.

Authors:  Ritesh Singh; Joshua N Kolev; Philip A Sutera; Rudi Fasan
Journal:  ACS Catal       Date:  2015-01-29       Impact factor: 13.084

Review 8.  Metallo-aminopeptidase inhibitors.

Authors:  Artur Mucha; Marcin Drag; John P Dalton; Paweł Kafarski
Journal:  Biochimie       Date:  2010-05-10       Impact factor: 4.079

9.  Synthesis of (2S,3R)-3-amino-2-hydroxydecanoic acid and its enantiomer: a non-proteinogenic amino acid segment of the linear pentapeptide microginin.

Authors:  Rajendra S Rohokale; Dilip D Dhavale
Journal:  Beilstein J Org Chem       Date:  2014-03-17       Impact factor: 2.883

10.  (tert-But-yl)(2-hy-droxy-eth-yl)ammonium chloride.

Authors:  Cintya Valerio-Cárdenas; Simón Hernández-Ortega; David Morales-Morales
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.